GLP-1 Boom Reshapes U.S. Food Costs and Markets
By late 2025, roughly 12% of U.S. adults were using GLP-1 weight-loss medications, a trend that is quietly trimming g...
By late 2025, roughly 12% of U.S. adults were using GLP-1 weight-loss medications, a trend that is quietly trimming g...
AI stocks are navigating a choppy market, but marquee names remain firmly in focus for long-term growth. Here’s a tim...
In June 2026, Bitcoin traders face a new threat: boredom. CryptoQuant sees a protracted lull in demand as the real ri...
Morgan Stanley filed amended registrations for ETH and SOL ETF trusts with a 0.14% sponsor fee, aiming to set a new p...
A practical view of living on a Greek island in retirement, with budget ranges, affordable island options, and health...
A political clash over Medicaid waivers that compensate family caregivers could redraw how millions support aging rel...
As inflation cools and markets favor quality cash flows, analysts say the dividend growth path that prioritizes risin...
MIT economist and public thinker Daron Acemoglu argues AI's productivity gains will be modest in the near term, while...
Bitcoin has pulled back from recent highs and trades near major support. Analysts debate whether the bottom is in, wi...
Binance founder CZ argues that AI agents could drive the next wave of crypto adoption by enabling autonomous, blockch...
With rates stabilizing in the mid-6% range, the housing market braces for a steadier second half of 2026. Pending sal...
Billionaire investor Mark Cuban warns popular bets could quietly erode wealth as funding costs rise and consumer conf...